DongBang Medical Holds NDR for Domestic Institutional Investors, Routine IR Activity with No Capital Impact
DongBang Medical will hold a Non-Deal Roadshow NDR for domestic institutional investors on June 25-26, 2026 in Yeouido, Seoul.
The NDR is sponsored by Sangsangin Securities and aims to enhance corporate and investment value through management updates and Q&A sessions.
This is a routine IR activity with no capital changes such as new share issuance, resulting in a neutral impact on existing shareholder value.
[AI Summary]DongBang Medical's NDR for institutional investors is a standard IR event without capital structure changes like equity issuance or convertible bonds. It has no direct effect on stock price or governance and is considered part of normal business operations.